Anavex Life Sciences Corp.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Anavex Life Sciences Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Anavex Life Sciences Corp. made a loss over the last year. Anavex Life Sciences Corp. owes $0.06 for every $1 it owns. Anavex Life Sciences Corp. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
LossAnavex Life Sciences Corp. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.12The share price is 1.12 times Anavex Life Sciences Corp.'s book value per share, lower than 76% of Healthcare companies in United States.
Market cap
$126 MThe total market value of all of Anavex Life Sciences Corp.'s shares at today's price (share price × number of shares), smaller than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$112 MWhat Anavex Life Sciences Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.21Net worth divided by the number of shares. The share price of $1.36 is 1.1 times this, which is the P/B above.
Return on equity (ROE)
-12.8%Anavex Life Sciences Corp. lost 12.8% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
Owes vs Owns
0.06×Anavex Life Sciences Corp. owes $0.06 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Dividend yield
NoneAnavex Life Sciences Corp. does not currently pay a dividend.
Profit growth
LossAnavex Life Sciences Corp. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Anavex Life Sciences Corp.: $126 M ÷ $112 M (30 Jun 2026) = 1.1.
What is Anavex Life Sciences Corp.'s return on equity?
Anavex Life Sciences Corp. lost 12.8% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
How much does Anavex Life Sciences Corp. owe compared with what it owns?
Anavex Life Sciences Corp. owes $0.06 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Does Anavex Life Sciences Corp. pay a dividend?
No. Anavex Life Sciences Corp. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.